Tweetovi

Blokirali ste korisnika/cu @shampadaspkpd

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @shampadaspkpd

  1. proslijedio/la je Tweet
    prije 13 sati

    Announcing exercise of $15.9M option by BARDA today for tebipenem HBr development. We continue to appreciate support in advancing tebipenem HBr, an oral carbapenem in a pivotal Phase 3 trial for the treatment of cUTI.

    Poništi
  2. proslijedio/la je Tweet
    prije 21 sat

    "Britain's Last Mass Quarantine" Am due on Wed 5th Feb with the wonderful discussing Britain’s last mass quarantine - Outbreak, Birmingham, 1978. A fascinating tale of tragedy and heroics, with lessons for

    , , i još njih 7
    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Developing next-gen drugs to fight superbugs - Bugworks story on Business Line...we are greatful to our collaborators&partners ⁦⁩ ⁦⁩ ⁦⁩ ⁦⁩ ⁦⁩ ⁦

    Poništi
  4. proslijedio/la je Tweet

    Thanks to £24m of funding, is set to lead a new research project to develop long-acting medicines that could transform the way the world prevents & treats and . Full story here ➡️

    , , i još njih 7
    Poništi
  5. proslijedio/la je Tweet
    1. velj

    Could not be more proud! Well done Andrew & Steve! Building on ⁦⁩ heritage in drug development & infectious disease research. £24m boost for Liverpool led revolutionary long-acting medicine research | EurekAlert! Science News

    Poništi
  6. proslijedio/la je Tweet

    In honour of , here’s 10 interesting facts about these hard to pronounce diseases (and the successful efforts to fight them) By 's : For Good. For All

    Poništi
  7. 30. sij

    Looking forward to speaking at in Infection meeting tomorrow

    Poništi
  8. proslijedio/la je Tweet
    23. sij

    This is a bit intense but that doesn’t make it less true. I had somebody visit me about ten years ago and panel 3 is a synopsis of what she said to me.

    Poništi
  9. proslijedio/la je Tweet
    24. sij

    An Excellent start to 2020! we have been just awarded a prestigious short term fellowship from National Centre for Infectious Disease (NCID), Singapore, for advancing our work on AMR. Thanks to collaborators, Prof Rajamani Lakshminarayanan and Prof Rachel

    Poništi
  10. proslijedio/la je Tweet
    24. sij

    Wonderful week for our amazing city & people: ⁦⁩ bringing together local,national & international colleagues to address the Grand Challenge ⁩ ⁦⁩ ⁦⁩ ⁦

    Poništi
  11. proslijedio/la je Tweet
    23. sij

    Your work is absolutely central to our goal of doing experimental medicine at scale and find ways to deploy new antibiotics in a sustainable way.

    Poništi
  12. proslijedio/la je Tweet
    23. sij
    Poništi
  13. proslijedio/la je Tweet
    23. sij
    Poništi
  14. 23. sij
    Poništi
  15. 23. sij
    Poništi
  16. proslijedio/la je Tweet
    Poništi
  17. proslijedio/la je Tweet
    22. sij

    Discovering new that are able to kill drug-resistant bacteria is essential to saving modern medicine. More from :

    Prikaži ovu nit
    Poništi
  18. proslijedio/la je Tweet
    22. sij

    Official launch of with our special guest opening our new funded laboratories. Exciting times!

    Poništi
  19. proslijedio/la je Tweet

    Congratulations on a wonderful event held last night to celebrate the foundation of the Dame Sally Davies Chair in antimicrobial research awarded to Professor William Hope

    Poništi
  20. 22. sij

    Great launch of Liverpool’s new Dame Sally Davies chair.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·